{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:14:39Z","timestamp":1794870879781,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the 2022 Key Scientific and Technological Project of Henan Science and Technology Department","award":["222102310340"],"award-info":[{"award-number":["222102310340"]}],"id":[{"id":"https:\/\/ror.org\/058p20n09","id-type":"ROR","asserted-by":"crossref"}]},{"name":"2022 Key Scientific Research Project of Universities of Henan Education Department","award":["22A310015"],"award-info":[{"award-number":["22A310015"]}]},{"name":"Doctoral Fund Project of Henan Polytechnic University","award":["B2021-68"],"award-info":[{"award-number":["B2021-68"]}],"id":[{"id":"https:\/\/ror.org\/05vr1c885","id-type":"ROR","asserted-by":"crossref"}]},{"name":"2022 Innovative Research Team of Henan Polytechnic University","award":["81803399"],"award-info":[{"award-number":["81803399"]}],"id":[{"id":"https:\/\/ror.org\/05vr1c885","id-type":"ROR","asserted-by":"crossref"}]},{"name":"2022 Innovative Research Team of Henan Polytechnic University","award":["T2022-3"],"award-info":[{"award-number":["T2022-3"]}],"id":[{"id":"https:\/\/ror.org\/05vr1c885","id-type":"ROR","asserted-by":"crossref"}]},{"name":"2020 Henan Provincial Colleges and Universities Youth Backbone Training Plan","award":["2020GGJS054"],"award-info":[{"award-number":["2020GGJS054"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171451"],"award-info":[{"award-number":["82171451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"2021 Key Scientific and Technological Project of Henan Science and Technology Department","award":["212102310774"],"award-info":[{"award-number":["212102310774"]}],"id":[{"id":"https:\/\/ror.org\/058p20n09","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Fundamental Research Funds for the Universities of Henan Province","award":["NSFRF220416"],"award-info":[{"award-number":["NSFRF220416"]}]},{"name":"College of Medicine-Beijing Bencaoyuan Pharmaceutical Co., Ltd Joint Scientific Research Project","award":["H20-523"],"award-info":[{"award-number":["H20-523"]}]},{"name":"2020 Joint Project of Henan Medical Science and Technology Research Program","award":["LHGJ20200829"],"award-info":[{"award-number":["LHGJ20200829"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81803399"],"award-info":[{"award-number":["81803399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple sclerosis (MS) is a chronic disease that is characterized by demyelination and neuronal damage. Experimental autoimmune encephalomyelitis (EAE) mice are used to model the disease progression of MS and mirror  MS-like pathology. Previous researches have confirmed that inhibition of NLRP3 inflammasome significantly alleviated the severity of EAE mice and the demyelination of spinal cord, but its effect on neuronal damage and oligodendrocyte loss in the brain remains unclear. In this study, female C57BL\/6 mice were immunized with MOG35\u201355 and PTX to establish experimental autoimmune encephalomyelitis (EAE) model. MCC950, a selective NLRP3 inflammasome inhibitor, was used to investigate the effect of NLRP3 inflammasome on the pathological changes and glial cell activation in the brain of EAE mice by immunohistochemistry. Our results demonstrated that MCC950 ameliorated the neuronal damage, demyelination, and oligodendrocyte loss in the brain of EAE mice. This protective effect of MCC950 may be attributed to its ability to suppress the activation of glial cells and prevents microglia polarization to M1 phenotype. Our work indicates that inhibition of NLRP3 inflammasome has the therapeutic effects of neuroprotection through immunomodulation and is a promising therapeutic strategy for MS.<\/jats:p>","DOI":"10.1007\/s12035-023-03618-y","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T05:02:06Z","timestamp":1694581326000},"page":"1318-1330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Inhibiting the NLRP3 Inflammasome with MCC950 Alleviates Neurological Impairment in the Brain of EAE Mice"],"prefix":"10.1007","volume":"61","author":[{"given":"Baohua","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baobao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijiao","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6979-840X","authenticated-orcid":false,"given":"Zhenhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"4","key":"3618_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","volume":"10","author":"MA Friese","year":"2014","unstructured":"Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10(4):225\u2013238. https:\/\/doi.org\/10.1038\/nrneurol.2014.37","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3618_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","volume":"52","author":"SL Hauser","year":"2006","unstructured":"Hauser SL, Oksenberg JR (2006) The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52(1):61\u201376. https:\/\/doi.org\/10.1016\/j.neuron.2006.09.011","journal-title":"Neuron"},{"issue":"11","key":"3618_CR3","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1007\/s12035-021-02497-5","volume":"58","author":"R Nasrnezhad","year":"2021","unstructured":"Nasrnezhad R, Halalkhor S, Sadeghi F, Pourabdolhossein F (2021) Piperine improves experimental autoimmune encephalomyelitis (EAE) in Lewis rats through its neuroprotective, anti-inflammatory, and antioxidant effects. Mol Neurobiol 58(11):5473\u20135493. https:\/\/doi.org\/10.1007\/s12035-021-02497-5","journal-title":"Mol Neurobiol"},{"issue":"8","key":"3618_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41573-022-00477-5","volume":"21","author":"L Bierhansl","year":"2022","unstructured":"Bierhansl L, Hartung HP, Aktas O, Ruck T, Roden M, Meuth SG (2022) Thinking outside the box: non-canonical targets in multiple sclerosis. Nat Rev Drug Dis 21(8):578\u2013600. https:\/\/doi.org\/10.1038\/s41573-022-00477-5","journal-title":"Nat Rev Drug Dis"},{"issue":"4","key":"3618_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164(4):1079\u20131106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"key":"3618_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","volume":"122","author":"AP Robinson","year":"2014","unstructured":"Robinson AP, Harp CT, Noronha A, Miller SD (2014) The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol 122:173\u2013189. https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00008-X","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"3618_CR7","doi-asserted-by":"publisher","first-page":"R844","DOI":"10.1152\/ajpregu.00528.2010","volume":"300","author":"A Panov","year":"2011","unstructured":"Panov A, Kubalik N, Zinchenko N, Ridings D, Radoff D, Hemendinger R, Brooks B, Bonkovsky H (2011) Metabolic and functional differences between brain and spinal cord mitochondria underlie different predisposition to pathology. Am J Physiol Regul Integr Comp Physiol 300(4):R844-854. https:\/\/doi.org\/10.1152\/ajpregu.00528.2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3618_CR8","doi-asserted-by":"publisher","first-page":"9238290","DOI":"10.1155\/2016\/9238290","volume":"2016","author":"K Zhou","year":"2016","unstructured":"Zhou K, Shi L, Wang Y, Chen S, Zhang J (2016) Recent advances of the NLRP3 inflammasome in central nervous system disorders. J Immunol Res 2016:9238290. https:\/\/doi.org\/10.1155\/2016\/9238290","journal-title":"J Immunol Res"},{"issue":"7","key":"3618_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","volume":"17","author":"H-H Shen","year":"2018","unstructured":"Shen H-H, Yang Y-X, Meng X, Luo X-Y, Li X-M, Shuai Z-W, Ye D-Q, Pan H-F (2018) NLRP3: a promising therapeutic target for autoimmune diseases. Autoimmun Rev 17(7):694\u2013702. https:\/\/doi.org\/10.1016\/j.autrev.2018.01.020","journal-title":"Autoimmun Rev"},{"key":"3618_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, Robertson AAB, Cooper MA, O\u2019Neill LAJ, Lynch MA (2017) Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain, Behav Immun 61:306\u2013316. https:\/\/doi.org\/10.1016\/j.bbi.2016.12.014","journal-title":"Brain, Behav Immun"},{"issue":"7434","key":"3618_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493(7434):674\u2013678. https:\/\/doi.org\/10.1038\/nature11729","journal-title":"Nature"},{"key":"3618_CR12","doi-asserted-by":"publisher","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, Robertson AAB, Butler MS, Rowe DB, O'Neill LA, Kanthasamy AG, Schroder K, Cooper MA, Woodruff TM (2018) Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Science translational medicine 10(465). https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","DOI":"10.1126\/scitranslmed.aah4066"},{"issue":"2","key":"3618_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/glia.23728","volume":"68","author":"V Deora","year":"2020","unstructured":"Deora V, Lee JD, Albornoz EA, McAlary L, Jagaraj CJ, Robertson AAB, Atkin JD, Cooper MA, Schroder K, Yerbury JJ, Gordon R, Woodruff TM (2020) The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia 68(2):407\u2013421. https:\/\/doi.org\/10.1002\/glia.23728","journal-title":"Glia"},{"issue":"225","key":"3618_CR14","doi-asserted-by":"publisher","first-page":"ra38","DOI":"10.1126\/scisignal.2002767","volume":"5","author":"M Inoue","year":"2012","unstructured":"Inoue M, Williams KL, Oliver T, Vandenabeele P, Rajan JV, Miao EA, Shinohara ML (2012) Interferon-\u03b2 therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci Signal 5(225):ra38. https:\/\/doi.org\/10.1126\/scisignal.2002767","journal-title":"Sci Signal"},{"issue":"26","key":"3618_CR15","doi-asserted-by":"publisher","first-page":"10480","DOI":"10.1073\/pnas.1201836109","volume":"109","author":"M Inoue","year":"2012","unstructured":"Inoue M, Williams KL, Gunn MD, Shinohara ML (2012) NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 109(26):10480\u201310485. https:\/\/doi.org\/10.1073\/pnas.1201836109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"3618_CR16","doi-asserted-by":"publisher","first-page":"10480","DOI":"10.1073\/pnas.1201836109","volume":"109","author":"M Inoue","year":"2012","unstructured":"Inoue M, Williams KL, Gunn MD, Shinohara ML (2012) NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci 109(26):10480\u201310485. https:\/\/doi.org\/10.1073\/pnas.1201836109","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"3618_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, Sutton CE, Nunez G, Latz E, Kastner DL, Mills KH, Masters SL, Schroder K, Cooper MA, O\u2019Neill LA (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21(3):248\u2013255. https:\/\/doi.org\/10.1038\/nm.3806","journal-title":"Nat Med"},{"issue":"7","key":"3618_CR18","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"NP Du Sert","year":"2020","unstructured":"Du Sert NP, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Hurst V, Karp NA, Lazic SE, Lidster K, Maccallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, W\u00fcrbel H (2020) Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biology 18(7):e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411","journal-title":"PLOS Biology"},{"issue":"12","key":"3618_CR19","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/nn.4421","volume":"19","author":"M Inoue","year":"2016","unstructured":"Inoue M, Chen PH, Siecinski S, Li QJ, Liu C, Steinman L, Gregory SG, Benner E, Shinohara ML (2016) An interferon-beta-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage. Nat Neurosci 19(12):1599\u20131609. https:\/\/doi.org\/10.1038\/nn.4421","journal-title":"Nat Neurosci"},{"issue":"5","key":"3618_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41419-020-2565-2","volume":"11","author":"B Hou","year":"2020","unstructured":"Hou B, Zhang Y, Liang P, He Y, Peng B, Liu W, Han S, Yin J, He X (2020) Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Cell Death Dis 11(5):377. https:\/\/doi.org\/10.1038\/s41419-020-2565-2","journal-title":"Cell Death Dis"},{"issue":"12","key":"3618_CR21","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1016\/j.ajpath.2014.08.019","volume":"184","author":"Ni Chen","year":"2014","unstructured":"Chen Ni, Chunhui W, Jingjing Z, Liwei Qu, Xiaoman L (2014) Interferon-\u03b3 safeguards blood-brain barrier during experimental autoimmune encephalomyelitis. Am J Pathol 184(12):3308\u20133320. https:\/\/doi.org\/10.1016\/j.ajpath.2014.08.019","journal-title":"Am J Pathol"},{"key":"3618_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnana.2019.00062","volume":"13","author":"F Zhong","year":"2019","unstructured":"Zhong F, Liu L, Wei J, Dai R (2019) Step by step Golgi-Cox staining for cryosection. Front Neuroanat 13:62. https:\/\/doi.org\/10.3389\/fnana.2019.00062","journal-title":"Front Neuroanat"},{"issue":"7878","key":"3618_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta M, Maric D, Gharagozloo M, Garton T, Smith MD, Jin J, Fitzgerald KC, Song A, Liu P, Lin J-P, Wu T, Johnson KR, McGavern DB, Schafer DP, Calabresi PA, Reich DS (2021) A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis. Nature 597(7878):709\u2013714. https:\/\/doi.org\/10.1038\/s41586-021-03892-7","journal-title":"Nature"},{"issue":"10","key":"3618_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/NEN.0b013e3181f3a5b1","volume":"69","author":"OW Howell","year":"2010","unstructured":"Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, Reynolds R (2010) Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol 69(10):1017\u20131033. https:\/\/doi.org\/10.1097\/NEN.0b013e3181f3a5b1","journal-title":"J Neuropathol Exp Neurol"},{"key":"3618_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI151803","author":"W Zhang","year":"2022","unstructured":"Zhang W, Xiao D, Li X, Zhang Y, Rasouli J, Casella G, Boehm A, Hwang D, Ishikawa LL, Thome R, Ciric B, Curtis MT, Rostami A, Zhang GX (2022) SIRT1 inactivation switches reactive astrocytes to an anti-inflammatory phenotype in CNS autoimmunity. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI151803","journal-title":"J Clin Invest"},{"key":"3618_CR26","doi-asserted-by":"publisher","unstructured":"Khaw YM, Tierney A, Cunningham C, Soto-Diaz K, Kang E, Steelman AJ, Inoue M (2021) Astrocytes lure CXCR2-expressing CD4(+) T cells to gray matter via TAK1-mediated chemokine production in a mouse model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 118 (8). https:\/\/doi.org\/10.1073\/pnas.2017213118","DOI":"10.1073\/pnas.2017213118"},{"key":"3618_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fncel.2019.00442","volume":"13","author":"W Kong","year":"2019","unstructured":"Kong W, Wang X, Yang X, Huang W, Han S, Yin J, Liu W, He X, Peng B (2019) Activation of TRPV1 contributes to recurrent febrile seizures via inhibiting the microglial M2 phenotype in the immature brain. Front Cell Neurosci 13:442. https:\/\/doi.org\/10.3389\/fncel.2019.00442","journal-title":"Front Cell Neurosci"},{"key":"3618_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molimm.2019.09.020","volume":"116","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zheng Y, Luo Y, Du Y, Zhang X, Fu J (2019) Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2\/ TLR4\/ NF-\u03baB pathways in BV2 cells. Mol Immunol 116:29\u201337. https:\/\/doi.org\/10.1016\/j.molimm.2019.09.020","journal-title":"Mol Immunol"},{"issue":"6","key":"3618_CR29","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.celrep.2017.04.047","volume":"19","author":"Y Shinozaki","year":"2017","unstructured":"Shinozaki Y, Shibata K, Yoshida K, Shigetomi E, Gachet C, Ikenaka K, Tanaka KF, Koizumi S (2017) Transformation of astrocytes to a neuroprotective phenotype by microglia via P2Y(1) receptor downregulation. Cell Rep 19(6):1151\u20131164. https:\/\/doi.org\/10.1016\/j.celrep.2017.04.047","journal-title":"Cell Rep"},{"issue":"4","key":"3618_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41582-022-00624-x","volume":"18","author":"LM Healy","year":"2022","unstructured":"Healy LM, Stratton JA, Kuhlmann T, Antel J (2022) The role of glial cells in multiple sclerosis disease progression. Nat Rev Neurol 18(4):237\u2013248. https:\/\/doi.org\/10.1038\/s41582-022-00624-x","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"3618_CR31","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41419-021-04450-9","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Hou B, Liang P, Lu X, Wu Y, Zhang X, Fan Y, Liu Y, Chen T, Liu W, Peng B, Yin J, Han S, He X (2021) TRPV1 channel mediates NLRP3 inflammasome-dependent neuroinflammation in microglia. Cell Death Dis 12(12):1159. https:\/\/doi.org\/10.1038\/s41419-021-04450-9","journal-title":"Cell Death Dis"},{"issue":"10","key":"3618_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41583-018-0053-9","volume":"19","author":"M Di Filippo","year":"2018","unstructured":"Di Filippo M, Portaccio E, Mancini A, Calabresi P (2018) Multiple sclerosis and cognition: synaptic failure and network dysfunction. Nat Rev Neurosci 19(10):599\u2013609. https:\/\/doi.org\/10.1038\/s41583-018-0053-9","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"3618_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA (2018) Multiple sclerosis. Nat Rev Dis Primers 4(1):43. https:\/\/doi.org\/10.1038\/s41572-018-0041-4","journal-title":"Nat Rev Dis Primers"},{"key":"3618_CR34","doi-asserted-by":"publisher","first-page":"1010304","DOI":"10.3389\/fimmu.2022.1010304","volume":"13","author":"M Melnikov","year":"2022","unstructured":"Melnikov M, Lopatina A (2022) Th17-cells in depression: Implication in multiple sclerosis. Front Immunol 13:1010304. https:\/\/doi.org\/10.3389\/fimmu.2022.1010304","journal-title":"Front Immunol"},{"key":"3618_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2017.00063","volume":"11","author":"L Song","year":"2017","unstructured":"Song L, Pei L, Yao S, Wu Y, Shang Y (2017) NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci 11:63. https:\/\/doi.org\/10.3389\/fncel.2017.00063","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"3618_CR36","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/labinvest.2010.6","volume":"90","author":"MO Ziehn","year":"2010","unstructured":"Ziehn MO, Avedisian AA, Tiwari-Woodruff S, Voskuhl RR (2010) Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab Vestig J tech Methods Pathol 90(5):774\u2013786. https:\/\/doi.org\/10.1038\/labinvest.2010.6","journal-title":"Lab Vestig J tech Methods Pathol"},{"issue":"6","key":"3618_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00401-019-02049-1","volume":"138","author":"M Lombardi","year":"2019","unstructured":"Lombardi M, Parolisi R, Scaroni F, Bonfanti E, Gualerzi A, Gabrielli M, Kerlero de Rosbo N, Uccelli A, Giussani P, Viani P, Garlanda C, Abbracchio MP, Chaabane L, Buffo A, Fumagalli M, Verderio C (2019) Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure. Acta Neuropathol 138(6):987\u20131012. https:\/\/doi.org\/10.1007\/s00401-019-02049-1","journal-title":"Acta Neuropathol"},{"issue":"4","key":"3618_CR38","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s13311-016-0477-8","volume":"13","author":"E Cekanaviciute","year":"2016","unstructured":"Cekanaviciute E, Buckwalter MS (2016) Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. Neurotherapeutics 13(4):685\u2013701. https:\/\/doi.org\/10.1007\/s13311-016-0477-8","journal-title":"Neurotherapeutics"},{"key":"3618_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.apcsb.2019.08.007","volume":"119","author":"M Olcum","year":"2020","unstructured":"Olcum M, Tastan B, Kiser C, Genc S, Genc K (2020) Microglial NLRP3 inflammasome activation in multiple sclerosis. Adv Protein Chem Struct Biol 119:247\u2013308. https:\/\/doi.org\/10.1016\/bs.apcsb.2019.08.007","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"7638","key":"3618_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M\u00fcnch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481\u2013487. https:\/\/doi.org\/10.1038\/nature21029","journal-title":"Nature"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03618-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T04:22:58Z","timestamp":1708921378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03618-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3618"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03618-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures complied with the Committee on the Ethics of Animal Experiments of Wuhan University (Permit Number: 2017083).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}